MMP9 and prostate cancer: In a study conducted by Mukherjee and colleagues, the authors reported that treatment with EGCG resulted in the inhibition of cytokine and chemokine gene induction, cell migration, and activity of MMP-9 and -2 in prostate cancer [43].